Tirzepatide, a dual GLP-1 and GIP receptor agonist, activates an additional appetite and metabolism pathway that semaglutide doesn't target
In this video, @lisa_jewell_md_plasticsurgery explains that treatment is highly individualized
Because these pathways are deeply intertwined with reproductive hormones, ovulation, endometrial health, and chronic pelvic inflammation, researchers have started examining how GLP-1 drugs influence fertility, PCOS, menstrual health, and endometrial disorders
Youre not alone in this journey, and there are ways to navigate the complexities to achieve sustainable results
GLP-1 agonist pills, which work in a similar way to weight-loss injections, are becoming available